---
title: "Alpha Tau Medical Ltd. (DRTS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DRTS.US.md"
symbol: "DRTS.US"
name: "Alpha Tau Medical Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T12:57:13.719Z"
locales:
  - [en](https://longbridge.com/en/quote/DRTS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DRTS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DRTS.US.md)
---

# Alpha Tau Medical Ltd. (DRTS.US)

## Company Overview

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.alphatau.com](https://www.alphatau.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -16.53 | 155 | - | - | - |
| PB | 13.55 | 132 | 8.06 | 4.69 | 3.97 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 75% |
| Hold | 1 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.68 |
| Highest Target | 15.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/DRTS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/DRTS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/DRTS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/DRTS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**